External organizationAlexion Pharmaceuticals

Basic data

Name:

Alexion Pharmaceuticals

Country:

United States

Region/province:

Massachusetts

City:

Boston

URL:

https://alexion.com/

Projects

ALXNWD1840 – A multicenter, randomized, controlled, open-label, rater-blinded study to evaluate efficacy, safety, pharmokokinetics and pharmacodynamics of ALXN1840 versus standard of care in pediatric participants with Wilson disease

2022 - 2027

Alexion Pharmaceuticals

Help

will be deleted permanently. This cannot be undone.